TREM2 and breast cancer: In anti-PD-1-treated BC patients, TREM2 TAMs (TREM2, CX3CR1, C3, PLD4, CCL3) were inversely correlated with T cell clonal expansion, suggesting an association with poor response to anti-PD-1 therapy [65].